20-51790268-C-A
Variant summary
Our verdict is Benign. Variant got -16 ACMG points: 0P and 16B. BP4_StrongBP6_Very_StrongBS2
The NM_020436.5(SALL4):c.2215G>T(p.Ala739Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00379 in 1,614,146 control chromosomes in the GnomAD database, including 18 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Consequence
NM_020436.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -16 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SALL4 | NM_020436.5 | c.2215G>T | p.Ala739Ser | missense_variant | 2/4 | ENST00000217086.9 | NP_065169.1 | |
SALL4 | XM_047440318.1 | c.1909G>T | p.Ala637Ser | missense_variant | 2/4 | XP_047296274.1 | ||
SALL4 | NM_001318031.2 | c.1150+1065G>T | intron_variant | NP_001304960.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SALL4 | ENST00000217086.9 | c.2215G>T | p.Ala739Ser | missense_variant | 2/4 | 1 | NM_020436.5 | ENSP00000217086 | P1 | |
SALL4 | ENST00000371539.7 | c.131-1127G>T | intron_variant | 1 | ENSP00000360594 | |||||
SALL4 | ENST00000395997.3 | c.1150+1065G>T | intron_variant | 1 | ENSP00000379319 |
Frequencies
GnomAD3 genomes AF: 0.00285 AC: 434AN: 152156Hom.: 1 Cov.: 32
GnomAD3 exomes AF: 0.00264 AC: 663AN: 251324Hom.: 2 AF XY: 0.00274 AC XY: 372AN XY: 135854
GnomAD4 exome AF: 0.00389 AC: 5689AN: 1461874Hom.: 17 Cov.: 31 AF XY: 0.00385 AC XY: 2801AN XY: 727240
GnomAD4 genome AF: 0.00284 AC: 433AN: 152272Hom.: 1 Cov.: 32 AF XY: 0.00270 AC XY: 201AN XY: 74452
ClinVar
Submissions by phenotype
not provided Benign:6
Likely benign, no assertion criteria provided | clinical testing | Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center | - | - - |
Likely benign, criteria provided, single submitter | clinical testing | GeneDx | Mar 22, 2021 | - - |
Likely benign, criteria provided, single submitter | clinical testing | Center for Pediatric Genomic Medicine, Children's Mercy Hospital and Clinics | Feb 13, 2017 | - - |
Likely benign, no assertion criteria provided | clinical testing | Genome Diagnostics Laboratory, University Medical Center Utrecht | - | - - |
Benign, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Jun 01, 2023 | SALL4: BP4, BS1, BS2 - |
Likely benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
not specified Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Eurofins Ntd Llc (ga) | Nov 12, 2014 | - - |
Duane-radial ray syndrome Benign:1
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Dec 21, 2023 | - - |
SALL4-related disorder Benign:1
Benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Jul 26, 2019 | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at